Books in a Library

A Family Diagnosed as MEN2A with a Rare Mutation D631Y in RET Oncogene

DOI: 
10.7727/wimj.2016.231

ABSTRACT

Multiple Endocrine Neoplasia type 2A (MEN 2A) is an autosomal dominant disease including medullary thyroid carcinoma (MTC), pheochromocytoma and primary hyperparathyroidism. Germline mutations in the RET proto-oncogene are well documented as the genetic cause of multiple endocrine neoplasia type 2A (MEN2A) and familial medullary thyroid carcinoma (FMTC).  Herein, we report a rare mutation of the RET gene (D631Y) in a Turkish family with MEN 2A. The presented case was diagnosed as pheochromocytoma and has got RET gene homozygote mutation, with no clinical evidence of MTC at the time of diagnosis. Four siblings of the patient were asymptomatic and each has got heterozygote mutation of D631Y (c.1891G›T). Three years after bilateral adrenalectomy due to pheochromocytoma, the patient was diagnosed with MTC and underwent total thyroidectomy.

Accepted: 
30 Jun, 2016
PDF Attachment: 
e-Published: 19 Jul, 2016

Disclaimer

Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.